Viewing Study NCT02163356


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2026-01-04 @ 1:48 PM
Study NCT ID: NCT02163356
Status: TERMINATED
Last Update Posted: 2022-03-31
First Post: 2014-05-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant Neuroblastoma
Sponsor: South Plains Oncology Consortium
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module